IGEA Pharma NV
F:3B5
IGEA Pharma NV
F:3B5
Price:
16.791
EUR
-3.07%
Market Cap:
€10.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
IGEA Pharma NV
F:3B5
|
NL |
|
Senestech Inc
NASDAQ:SNES
|
US |
|
D
|
Dorchester Minerals LP
NASDAQ:DMLP
|
US |
|
Delta Oil & Gas Inc
OTC:DLTA
|
CA |
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
M
|
Morixe Hermanos SACI
BCBA:MORI
|
AR |
|
Feitian Technologies Co Ltd
SZSE:300386
|
CN |
|
I
|
Intermonte Partners Sim SpA
MIL:INT
|
IT |
Balance Sheet
Balance Sheet Decomposition
IGEA Pharma NV
IGEA Pharma NV
Balance Sheet Decomposition is not available for
IGEA Pharma NV
IGEA Pharma NV
Balance Sheet
IGEA Pharma NV
IGEA Pharma NV
Currency: EUR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
3
|
1
|
0
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
1
N/A
|
1
+18%
|
1
-13%
|
3
+427%
|
1
-69%
|
1
-32%
|
11
+1 539%
|
0
-98%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
|
| Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+61%
|
1
-3%
|
1
-32%
|
0
-45%
|
0
+2%
|
2
+334%
|
3
+18%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Retained Earnings |
0
|
1
|
1
|
2
|
0
|
0
|
10
|
22
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
|
| Total Equity |
0
N/A
|
1
-186%
|
1
-9%
|
2
N/A
|
1
-78%
|
0
-62%
|
9
+4 383%
|
2
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+18%
|
1
-13%
|
3
+427%
|
1
-69%
|
1
-32%
|
11
+1 539%
|
0
-98%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
25
|
25
|
25
|
334
|
337
|
|
Switch to:
Switch to:
See Also
Discover More
